Robert B Clarke

12PUBLICATIONS
85CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer cell biologyMolecular targetsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Nov 05, 2025
Anti-progestin therapy targets hallmarks of breast cancer risk.

Bruno M Simões, Robert Pedley, Curtis W McCloskey

|Jul 14, 2023
Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research.

Renée van Amerongen, Mohamed Bentires-Alj, Antonius L van Boxtel

|Jan 04, 2023
RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells.

Fuhui Chen, Sevim B Gurler, David Novo

|Nov 14, 2022
Author Correction: High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.

Marta Palafox, Laia Monserrat, Meritxell Bellet

|Sep 07, 2022
High p16 expression and heterozygous RB1 loss are biomarkers for CDK4/6 inhibitor resistance in ER+ breast cancer.

Marta Palafox, Laia Monserrat, Meritxell Bellet

|Apr 15, 2022
Preclinical In Vivo Validation of the RAD51 Test for Identification of Homologous Recombination-Deficient Tumors and Patient Stratification.

Benedetta Pellegrino, Andrea Herencia-Ropero, Alba Llop-Guevara

Pageof 2

Frequent Collaborators

5 joint publications

Bruno M Simões

4 joint publications

Carlos Caldas

4 joint publications

Sacha J Howell

3 joint publications

Joaquín Arribas